Advertisements


Stealth Biotherapeutics reports Q1 EPS (20c), consensus (35c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Stealth Biotherapeutics reports Q3 EPS (4c), consensus (4c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 14th, 2019

Stealth BioTherapeutics reports Q2 EPS (4c), consensus (8c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 14th, 2019

Stealth Biotherapeutics reports Q1 EPS (20c), consensus (35c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Arcutis Biotherapeutics reports Q1 EPS ($1.15), consensus (92c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 12th, 2020

Aeglea BioTherapeutics reports Q1 EPS (57c), consensus (66c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 7th, 2020

Atara Biotherapeutics reports Q1 EPS ($1.20), consensus ($1.41)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 6th, 2020

Stealth BioTherapeutics Reports Fiscal Year 2019 Financial Results And Recent Business Highlights

BOSTON, April 1, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO), a clin.....»»

Category: earningsSource: benzingaApr 1st, 2020

Atara Biotherapeutics reports Q4 EPS ($1.36), consensus ($1.34)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 27th, 2020

Iovance Biotherapeutics reports Q4 EPS (50c), consensus (91c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2020

Aeglea BioTherapeutics reports FY19 EPS ($2.45), consensus ($2.48)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 24th, 2020

Atara Biotherapeutics reports Q3 EPS ($1.31), consensus ($1.44)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 7th, 2019

Aeglea BioTherapeutics reports Q3 EPS (66c), consensus (54c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 6th, 2019

Iovance Biotherapeutics reports Q3 EPS (40c), consensus (39c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 4th, 2019

Stealth BioTherapeutics Reports First Half 2019 Financial Results And Recent Business Highlights

BOSTON, Aug. 14, 2019 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology co.....»»

Category: earningsSource: benzingaAug 14th, 2019

Atara Biotherapeutics reports Q2 EPS ($1.60), consensus ($1.50)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 8th, 2019

Aeglea BioTherapeutics reports Q2 EPS (55c), consensus (49c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 6th, 2019

Iovance Biotherapeutics reports Q2 EPS (38c), consensus (29c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2019

Atara Biotherapeutics reports Q1 EPS ($1.44), consensus ($1.51)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 9th, 2019

Stealth Biotherapeutics reports "positive" results for elamipretide

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 30th, 2019

Atara Biotherapeutics reports Q1 EPS ($1.05), consensus (92c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 8th, 2018